Skip to main content

URIMAR-T CAPS

NDC 28595-224 · Allegis Pharmaceuticals, LLC

Generic namemethenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate
Dosage formCAPSULE
RouteORAL
Active ingredient(s)METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFATE
Strength.12; 120; 10.8; 36.2; 40.8 mg/1; mg/1; mg/1; mg/1; mg/1
Pharmacologic classOxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]
Marketing categoryUNAPPROVED DRUG OTHER

Packages

28595-224-60 — 60 CAPSULE in 1 BOTTLE (28595-224-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

12539-144 — Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate, 14537-832 — Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and…, 14537-833 — Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and…, 14789-119 — Methylene Blue, 15243-344 — METHYLENE BLUE, 16477-738 — Hyoscyamine Sulfate, 17856-0125 — Phenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide, 17856-0511 — Hyoscyamine Sulfate, 17856-0514 — Hyoscyamine Sulfate, 23731-7000 — Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate, 28595-299 — methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate, 36800-314 — METHENAMINE, SODIUM SALICYLATE, 39328-049 — Hyoscyamine Sulfate, 39328-050 — Hyoscyamine Sulfate, 39328-051 — Hyoscyamine Sulfate, 39328-052 — Hyoscyamine Sulfate, 41250-557 — METHENAMINE, SODIUM SALICYLATE, 42192-338 — hyoscyamine sulfate, 42192-339 — hyoscyamine sulfate, 42192-340 — hyoscyamine sulfate, +145 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels